Pembrolizumab生物仿制藥是一種人源化單克隆抗體,可阻斷PD-1與其配體PD-L1和PD-L2之間的相互作用。它是一種IgG 4 κ免疫球蛋白,分子量約為149 kDa。 Toripalimab生物仿制藥-研究級(jí)該產(chǎn)品同種型對(duì)照:Bulk Human IgG4 Isotype Control (IB4) [ICH2257] 緩沖液:ICH3002 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:<1EU/mg Determined by LAL gel clotting assay 制劑:Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.